Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-442-4 | CAS number: 7553-56-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: 315 mg/kg (rats)
Acute inhalation toxicity: >4.588 mg/L air (rats)
Acute dermal toxicity: 1425 mg/kg bw (rabbits)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Data waiving:
- other justification
- Justification for data waiving:
- the study does not need to be conducted because a study on acute toxicity by the inhalation route is available
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Handbook data
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Handbook data, no info presented
- GLP compliance:
- not specified
- Species:
- mouse
- Route of administration:
- oral: unspecified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 1 425 mg/kg bw
- Based on:
- element
- Conclusions:
- The acute oral median lethal dose (LD50) for potassium iodide in mice was 1425 mg iodide /kg bw.
- Executive summary:
The acute oral median lethal dose (LD50) for potassium iodide in mice was 1425 mg iodide /kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Handbook data
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Handbook data, no info presented
- GLP compliance:
- not specified
- Species:
- rat
- Route of administration:
- oral: unspecified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 3 320 mg/kg bw
- Based on:
- element
- Conclusions:
- The acute oral median lethal dose (LD50) for potassium iodide in rats was 3320 mg iodide /kg bw.
- Executive summary:
The acute oral median lethal dose (LD50) for potassium iodide in rats was 3320 mg iodide /kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Data set by U.S. Environmental Protection Agency
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Purity: 99.5%
- Species:
- rat
- Route of administration:
- oral: unspecified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 315 mg/kg bw
- Based on:
- test mat.
- Conclusions:
- LD50 is 315 mg/kg to rats.
- Executive summary:
- The acute oral LD50 of iodine (99.5% a.i.) is 315 mg/kg to rats.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 315 mg/kg bw
- Quality of whole database:
- 2 (reliable with restrictions)
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2008-08-31 to 2008-09-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- May 1981
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate attached
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- Analysed Purity : 99.8%
Batch NO.: 182670986
Appearance/Colour/Odour : Prills, bluish-black with metallic luster coloured with pungent odour - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Animal Breeding Facility, Jai Research Foundation
- Age at study initiation: 10-11 weeks
- Weight at study initiation: Male 255-282 g, females 195-218 g.
- Fasting period before study: No
- Housing: Groups of five animals were housed in polypropylene rat cages each fitted with a stainless steel grid on top.
- Diet (e.g. ad libitum): ad libitum, except during exposure
- Water (e.g. ad libitum): ad libitum, except during exposure
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23 °C
- Humidity (%): 64-66
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours darkness - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: DMSO
- Mass median aerodynamic diameter (MMAD):
- 3.58 µm
- Geometric standard deviation (GSD):
- 3.15
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Inhalation equipment head/nose only exposure supplied by BIO-TOX Instrumentation International, New Delhi, India.
- Exposure chamber volume: 63.5 L
- Method of holding animals in test chamber: Exposure unit with port-holes to accommodate transparent rat exposure tubes
- Source and rate of air: Filtered air, 12-15 air changes per hour
- Method of conditioning air: Filter
- System of generating particulates/aerosols: Spray atomizer
- Method of particle size determination: Seven stage cascade impactor (Model No 02-150)
- Treatment of exhaust air: 1% sodium hydroxide solution, and moisture traps containing silica gel.
- Temperature, humidity, pressure in air chamber: 20.2-23.1 (°C), 43.7-50.5 (% RH), slight negative pressure
TEST ATMOSPHERE
- Brief description of analytical method used: Gravimetric concentration analysis. A suitable measured volume of air was drawn from the inhalation chamber at the level of the breathing zone at every one hour of exposure after equilibration of the chamber for 30 minutes). At the end of air sampling, glass microfibre papers with the test substance were weighed to determine the concentration of iodine aerosols.
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle (if applicable): dimethyl sulphoxide
- Concentration of test material in vehicle (if applicable): Stock solution 500 mg/L
TEST ATMOSPHERE
- Particle size distribution: See table 1
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): MMAD 3.58 µm, GSD 3.15 - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- gravimetric analysis
- Duration of exposure:
- 4 h
- Concentrations:
- 4.588 mg/L and control
- No. of animals per sex per dose:
- 5 males and 5 females in tested dose and control group
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Hourly intervals during the 4 h exposure period and at 1 h after the exposure on the day of exposure. Subsequently, twice a day for morbidity and mortality for a period of 14 days following exposure. Body weights recorded prior to exposure on day 0, day 7, 14 and at death.
- Necropsy of survivors performed: yes - Statistics:
- As this study was conducted as a limit test, no statistical analyses was required. Body weight data was statistically analysed following Student's 't' test.
- Preliminary study:
- A dose range finding study for test item was performed using four rats (2 males and 2 females) per group at the nominal concentration of 11.111 and 22.222 mg/L air and breathing zone concentration determined 2.626 and 4.629 mg/L air, respectively. 0 and 25% morality was observed in rats treated with 2.626 and 4.629 mg/L air respectively. As only 25% mortality was observed at maximum attainable concentration (4.629 mg/L air) hence, the main study was conducted as limit study at the nominal concentration of 22.222 mg/L air for group II.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 4.588 mg/L air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- other: Maximum achievable concentration
- Mortality:
- 3 rats from group II (1 male and 2 female died between day 1 and 3 post exposure). No mortality occurred in control group.
- Clinical signs:
- other: Toxic signs like lethargy, abdominal breathing, nasal discharge and nasal irritation were observed in the treatment group rats. The above symptoms were observed from 4 h during exposure and the surviving rats appeared normal from day 5 post exposure until
- Body weight:
- At the end of the observation period the mean weight of surviving rats belonging to the treatment group were comparable to that of the control group rats.
- Gross pathology:
- External examination of found dead and terminally sacrificed rats did not reveal any lesion of pathological significance. Visceral examination of the found dead rats from the treatment group revealed varying degree of lesions like lung congestion, lung haemorrhage. Terminally sacrificed rats belonging to both control and the treatment group did not reveal any lesion of pathological significance except, uterus distended (not correlated with the test substance).
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- Under testing conditions, the acute median lethal concentration (LC50) of test item was found to be greater than 4.588 mg /L air in Wistar rats.
- Executive summary:
The study was performed to assess the acute inhalation toxicity (LC50) of test item in Wistar rats. The method followed was as per the Guideline of OECD No 403 (May 1981).
Based on the results obtained from the range finding study, two groups of rats, each consisting of five male and five females rats were used for the main study. Rats from group I were exposed to aerosols of dimethyl sulphoxide only and served as the control group. Rats from group II were exposed to breathing zone concentration of 4.588 mg/L of air. Rats from both groups were exposed for 4 hours followed by observation for a period of 14 days. No toxic sign and no mortality were observed in the rats of the control group (group I), whereas toxic signs like lethargy, abdominal breathing, nasal discharge and nasal irritation were observed in the treatment group rats. Percent mortality observed (both the sexes combined) was 30% at the maximum attainable breathing zone concentration of 4.588 mg/L of air. The incidence and severity of vascular changes observed in found dead rats of the treatment group could be correlated with treatment.
As 30% mortality was observed in the treatment group at the maximum achievable breathing zone concentration (4.588 mg/L air) of test item in present study, the acute median lethal concentration (LC50) of test item was found to be greater than 4.588 mg/L air.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 4 588 mg/m³ air
- Quality of whole database:
- 1 (reliable without restriction)
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2005-11-30 to 2006-01-17
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Version / remarks:
- August 1998
- Deviations:
- yes
- Remarks:
- 4-h systemic observations for the 500 mg/kg dose level were inadvertently not recorded. This did not affect the outcome of the study since the animals appeared normal at the 2-h and day 1 of the observation periods.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Millbrook Breeding Labs, Amherst, MA
- Age at study initiation: approximately 3 months old
- Weight at study initiation: 2.3-3.3 kg males and 2.7-3.3 kg for females
- Fasting period before study: None
- Housing: 1 animal per cage (suspended wire cages)
- Diet (e.g. ad libitum): Fresh purina Rabbit Chow daily
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Temperature was controlled, but no data presented
- Humidity (%): No data
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12 h light/dark cycle - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal area of the trunk
- % coverage: 10% of the body weight
- Type of wrap if used: surgical gauze patch and plastic with non-irritating tape
REMOVAL OF TEST SUBSTANCE
- Washing (if done): gently washing with distilled water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): dose level 2000 mg/kg: 5.4-6.6 (g); 1000 mg/kg: 2.3-2.5 (g); 500 mg/kg: 1.35-1.60 (g)
- For solids, paste formed: yes
VEHICLE
- Amount(s) applied (volume or weight with unit): 0.25-1.0 mL - Duration of exposure:
- 24-h
- Doses:
- 2000, 1000, 500 mg/kg bw
- No. of animals per sex per dose:
- At 2000 mg/kg bw five males and five females, at 1000 mg/kg bw five males, and at 500 mg/kg bw five males
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Toxicity: 1,2 and 4 hours postdose and once daily for 14 days. Mortality: twice daily for 14 days. Body weights: pretest, weekly and at study/termination.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology, other: dermal irritation - Statistics:
- LD50, 95% confidence limits according to Litchfield, J.T., Jr. & Wilcoxon, F. F., JPET 96:99, 1949.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 425 mg/kg bw
- 95% CL:
- > 996 - < 2 038
- Mortality:
- 2000 mg/kg bw: one of five males and three of five females survived
1000 mg/kg bw: four of five males survived
500 mg/kg bw: all five males survived - Clinical signs:
- other: 2000 mg/kg bw Predeath: few feces, emaciation, soiling of the anogenital area, lethargy and nose/mouth area stained brown. In the survivors: instances of few faeces and soiling of the anogenital area. 1000 mg/kg bw Predeath: diarrhoea and soiling of the
- Gross pathology:
- 2000 mg/kg bw:
Dead animals: abnormalities of the treated skin, lungs, kidneys, liver, stomach, intestines, peritoneal cavity and spleen. Soiling of the anogenital cavity, emacination, brown staining of the nose/mouth area and excess fluid in the abdominal cavity.
Survivors: abnormalities of the spleen, kidneys, intestines, treated skin, thymus, pancreas and testicle, as well as soiling of the anogenital area.
1000 mg/kg bw:
dead animals: abnormalities of the treated skin, lungs, liver, kidneys, intestines, spleen and stomach, as well as brown staining of the nose/mouth area and soiling of the anogenital area.
Survivors: abnormalities of the treated skin, spleen, kidneys, thymus and pancreas.
500 mg/kg bw
Abnormalities of the treated skin, pancreas, thymus and spleen. - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under testing conditions, the dermal LD50 of iodine in male rabbits is 1425 mg/kg bw. It appeared that females are not markedly more sensitive to the substance and the LD50 in females is greater than 2000 mg/kg bw.
- Executive summary:
To determine the potential for toxicity of iodine when applied dermally, the substance was tested following set forth in US EPA Health Effects Testing Guidelines, OPPTS 870.1200, final guideline, August 1998.
Five healthy male and healthy female New Zealand White rabbits were dosed dermally with iodine at 2000 mg/kg bw. Since compound related mortality occurred at this level, five additional males were dosed at 1000 mg/kg bw and five males were dosed at 500 mg/kg bw. The test article was kept in contact with the skin for 24 h. Animals were observed for toxicity and mortality at 1, 2 and 4 hours postdose and daily for 14 days. Body weights and gross pathology were examined in all animals.
The dermal LD50 and 95% confidence limits of iodine in male rabbits is 1425 (996 -2038) mg/kg bw. It appeared that females are not markedly more sensitive to the substance and the LD50 in females is greater than 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 425 mg/kg bw
- Quality of whole database:
- 2 (reliable with restrictions)
Additional information
Iodine is classified under Regulation (EC) 1272/2008 (Annex VI Table 3.2.) as Acute Tox. 4 (H332, H312).
Tests results are in line with the current classification of the substance, although in the case of acute inhalation toxicity, the LC50 is expected to be slightly over the threshold. Based of the fact that 30% of animals died at the maximum achievable concentration, the result is considered as a borderline case. However, after taking into account the current harmonized classification the LC50 is set at 4.588 mg/L air.
Two authority reviews have published values for the acute oral toxicity of iodine:
- 315 mg/kg (rats) by the United States Environmental Protection Agency, and
- 1840 mg/kg (rats) by the United Nations.
As this information has come from recognised reliable sources, the primary information sources cited have not been revisited as suggested in the Guidance for the implementation of REACH- Guidance on information requirements and chemical safety assessment: Chapter R3: Information gathering. Furthermore, in accordance with Column 2 of REACH Annex VII, study for acute oral toxicity need not be conducted if an acute toxicity study by the inhalation route is available.
Based on the most conservative value, for classification and labelling purposes, the acute oral toxicity of iodine is set at 315 mg/kg.
References:
- United Nations. 2008. Committee of experts on the transport of dangerous goods and on the globally harmonized system of classification and labelling of chemicals. Sub-committee of experts on the transport of dangerous goods. Thirty-third session. Geneva, 30 June-9July 2008. Item 4 of the provisional agenda. Listing, classification and packing. New entry for iodine, raw in class 8. Submitted by the expert from Germany.
- United States Environmental Protection Agency. 2006. Reregistration eligibility decision for iodine and iodophor complexes.
Justification for classification or non-classification
Iodine has a harmonized EC classification under CLP Regulation 1272/2008. The acute oral toxicity of iodine (in rats) is set at 315 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.